New York Medical College

Jan Geliebter, Ph.D.

Professor - Department of Microbiology and Immunology and Otolaryngology
Resident Research Coordinator - Department of Otolaryngology
Course Director - Medical Microbiology
Regional Vice President - Executive Committee of Faculty Senate
Member - Executive Committee of Education and Curriculum

Jan GeliebterEmail:

jan_geliebter@nymc.edu

Address:

Dept. of Microbiology & Immunology
Basic Sciences Building Room 311
New York Medical College
Valhalla, NY 10595

 

Professional Interests:

Thyroid cancer
-  Identification of molecular biomarkers for the diagnosis and prognosis of papillary thyroid cancer
-  Elucidation of the molecular basis of papillary thyroid cancer

Prostate cancer
- Investigation of the synergistic effect of aging and a high fat diet on inflammation in the prostate and prostate carcinogenesis
- Role of fetal exposure to environmental/dietary carcinogens (such as PhIP) on adult onset prostate cancer
- Immunotherapy of prostate cancer

Antimicrobials
-Analysis of antimicrobial properties of natural compounds

Education Profile:

Graduate Degree:
Ph.D.

Graduate Degree Institution: 
State University of New York Health Science Center at Brooklyn

Undergraduate Institution:
Hebrew University of Jerusalem, Israel,  BSc, Biology

Selected Bibliography:

Zeoli, C.D., Maitland, M., Rose, H., Bloom, B.R., Mittleman, A.  and Geliebter, J. 2001. Expression of Prostate Specific Molecules in Bacille Calmette-Guerin (BCG): An  Immunotherapeutic Approach to Prostate Cancer.  Prostate J. 3:92-97.

Geliebter, J. Chemokines:  small, but powerful regulators of the immune system – potential anti-tumor targets and reagents. 2002. Cancer Investigation. 20:857-858.

Reyes, N., Iatropoulos, M., Mittelman, A. and Geliebter, J Microarray analysis of diet-induced alterations in gene expression in the ACI rat prostate. 2002.  European J. Cancer Prev.  11: S37-S42.

Geliebter, J., Mittelman, A.and Tiwari, R.K. 2003.  Molecular Phenotyping of the Immune System by Microarray Analysis. Cancer Investigation.  21, 289-299.

Kanduc D, Capuano F, Capurso SA, Geliebter J, Guercia D, Lucchese A, Mittelman A, Simone SM, Sinha AA, Tiwari R, Farber E..  2003.  Cancer prevention and therapy: strategies and problems. J Exp Ther Oncol. 3:108-14.

Reyes, N., Reyes, I. Tiwari, R.K., and Geliebter, J. 2004. Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D.  2004. Cancer Letters. 209:25-35.

Liu, X., Tiwari, R.K., Geliebter, J., Wu, JM and Godfrey, H.P. 2004.  Interaction of a Mycobacterium tuberculosis repetitive DNA sequence with eukaryotic proteins. Biochem Biophys. Res. Comm.  320:966-972.

Tiwari, R., Geliebter, J.,  Lucchesea, A., Mittelman, A. and Kanduc, D.  2004. Computational peptide dissection of Melan-A/MART-1 oncoprotein antigenicity. Peptides  25:1865-71.

Reyes, I., Reyes, N., Iatropoulos, M., Mittelman, A. and J. Geliebter. 2005 Aging-associated changes in gene expression in the ACI rat prostate: implications for carcinogenesis. The Prostate. 63:169-86.

Tadi, K. Chang, C., Ashok, B.T., Chen, Y., Moscatello, A., Schaefer, S.D., Schantz, S.P., Policastro, A.J., Geliebter, J., Tiwari, R.K.  2005. 3,3’Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease.  Biochem Biophys. Res. Comm. 337(3):1019-25. 

Kanduc, D., Geliebter, J., Lucchese, J., Mazzanti, R., Mittelman, A., Polimeno, L., Ponzetto, A., Santacroce, R., Simone, S., Sinigaglia, E., Sinha, A., Tessitore, L., Tiwari, R.K., Farber, E. 2005. Gene therapy in cancer: the missing point.  Journal of Experimental Therapeutics and Oncology 5: 151-158

Suriano R, Lin Y, Ashok BT, Schaefer SD, Schantz SP, Geliebter J, Tiwari RK. 2006. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases  J Proteome Res. 5: 856-61

Reyes, N. Reyes, I. Tiwari, R. and Geliebter, J. 2007. Microarray analysis reveals metastasis associated genes in prostate cancer cell lines. Biomedica, 27:190-203.

Rajoria, Shilpi, Suriano, Robert, Shanmugan, Aulkumaran, Wilson, Yushan, Schantz, Stimson, Geliebter, Jan and Tiwari, Raj.  2010  Metastatic phenotype is regulated by estrogen in thyroid cancer.  Thyroid. 20(1):33-41.

Hofkamp, L., Bradley, S., Geliebter, J. and Timms, B. 2010.  Atypical fetal prostate development is associated with ipsilateral hypoplasia of the Wolffian ducts in the ACI rat. The Anatomical Record.  293:747-53.

Theodore S. Nowicki, Nicolas T. Kummer, Codrin Iacob, Nina Suslina, Augustine Moscatello,  Steven Schaefer,  Stimson Schantz, Edward Shin, Raj K. Tiwari, and Jan Geliebter. 2010. uPA and uPAR Promote Invasion and Metastasis in Papillary Thyroid Carcinoma Cells. Laryngoscope. 120:1383-90.

Shilpi Rrajoria, Robert Suriano, Arulkumaran Shanmugam, Andrea George, Stimson Schantz, Jan Geliebter, and Raj Tiwari. 2011  3,3'-diindolylmethane inhibits estrogen mediated metastatic propensity of thyroid cancer.  Thyroid. 20:33-41.

Theodore S. Nowicki, Hong Zhao, Zbigniew Darzynkiewicz,, Stimson Schantz, Edward Shin,  Raj K. Tiwari, and Jan Geliebter. 2011 Down-regulation of uPAR inhibits migration, invasion, proliferation, and FAK/PI3K/Akt signaling in papillary thyroid carcinoma cells. Cell Cycle. 10:100–107.  

Rajoria S, Suriano R, Wilson YL, Schantz SP, Moscatello A, Geliebter J, Tiwari RK. 2011. 3,3’-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways. Oncology Reports. 25: 491-497.

Rajoria S, Suriano R, Wilson YL, Schantz SP, George A, Geliebter J, Schantz SP and Tiwari RK. 2011. Estradiol Mediated Tumor Neovascularization. Oncology Letters. In press.

Rajoria S, Suriano R, Wilson YL, Schantz SP, Moscatello A, Geliebter J, Tiwari RK. 2011. Metastatic modulators MMP2/MMP9 are targets of the antiestrogen DIM in thyroid cancer: Implication for cancer prevention and diagnosis. PLOS ONE. 6:1-11.

E.Ashlie Darr, Anand D. Patel,  Zbigniew Komorowski, Steven McCormick  Stimson P. Schantz, Raj Tiwari and Jan Geliebter.  Reduced Cx43 Expression Differentiates Follicular Thyroid Carcinoma from Follicular Adenoma.  Otolaryngology -- Head and Neck Surgery.  In press